Early Intervention May Be Better for Severe Asymptomatic Aortic Stenosis
FRIDAY, May 20, 2022 (HealthDay News) -- For patients with severe asymptomatic aortic stenosis, early intervention may reduce the risk for all-cause mortality compared with conservative management, according to a systematic review and meta-analysis published online May 17 in Open Heart.
Vasiliki Tsampasian, M.D., from Norfolk and Norwich University Hospital in the United Kingdom, and colleagues conducted a systematic review and meta-analysis to examine data relating to the management of severe asymptomatic aortic stenosis. The strategies of early intervention and conservative management were compared.
The researchers found that based on a meta-analysis of data from two published randomized trials, including 302 patients, early intervention resulted in a significant reduction in all-cause mortality and in the risk for hospitalization for heart failure. No difference was seen between the groups in terms of risk for cardiovascular death. Patients treated with early intervention demonstrated improved mortality in a meta-analysis of data from eight observational studies.
"This meta-analysis shows that the data from the two recent large randomized controlled trials and previous observational studies demonstrate a favorable outcome in the group of patients treated with early intervention rather than conservative management," the authors write. "Although this may herald the beginning of a change in the management of these patients, further randomized controlled studies are needed to draw firm conclusions and identify the optimal timing of intervention."
Related Posts
Renal Impairment Linked to Worse Prognosis in IgD Multiple Myeloma
TUESDAY, Dec. 20, 2022 (HealthDay News) -- For patients with immunoglobulin D...
Otro beneficio del deporte para los niños: unos ojos más sanos
JUEVES, 6 de octubre de 2022 (HealthDay News) -- A veces, las alergias pueden...
Advances in Care, Impact of COVID Highlights of Latest Cardiologists’ Meeting
FRIDAY, Nov. 19, 2021 (HealthDay News) -- The COVID-19 pandemic, heart-healthy...
Un panel asesor de la FDA se reunirá para hablar sobre las dosis de refuerzo contra la COVID
VIERNES, 17 de septiembre de 2021 (HealthDay News) -- Los asesores de la...